US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
Hosted on MSN19d
Kenox and Lactiga partner on sIgA therapies for immunodeficiency
The company, established in 2018 and based in the US state of New Jersey, focuses on pharma aerosol product development ... "Immunologists have long sought a nasal sIgA spray to reduce recurrent ...
The Boston Globe5d
Treatment for traumatic brain injury could come in the form of a nasal spray drug, study says
A recent study led by Mass General Brigham researchers found that a nasal spray developed to target inflammation in the brain could be used to treat chronic symptoms of traumatic brain injury.
Nature1mon
Deposition of Aerosol Particles in the Nasopharyngeal Region of the Human Respiratory Tract
Investigations in the Health Physics and Medical Division at AERE, Harwell, into the behaviour of inhaled radioactive aerosol particles in the human respiratory tract have started—with the ...